These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 10912698
1. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Sockalingam R, Freeman S, Cherny TL, Sohmer H. Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698 [Abstract] [Full Text] [Related]
3. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D. Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950 [Abstract] [Full Text] [Related]
4. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses. Mills DM. Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501 [Abstract] [Full Text] [Related]
5. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Daldal A, Odabasi O, Serbetcioglu B. Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639 [Abstract] [Full Text] [Related]
8. [Evaluation of the protective effect of magnesium on amikacin ototoxicity by electrophysiologic tests in guinea pigs]. Bulut E, Yağiz R, Taş A, Uzun C, Yildirim C, Kaymak K, Karasalioğlu AR. Kulak Burun Bogaz Ihtis Derg; 2005 Nov; 15(3-4):70-7. PubMed ID: 16340296 [Abstract] [Full Text] [Related]
9. End points for cisplatin ototoxicity. Qureshy K, Blakley B, Alsaleh S, Quddusi T, Berard S. J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S45-8. PubMed ID: 21453661 [Abstract] [Full Text] [Related]
17. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I. Oncology; 2006 May 31; 70(3):177-84. PubMed ID: 16757924 [Abstract] [Full Text] [Related]
18. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. Knight KR, Kraemer DF, Winter C, Neuwelt EA. J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008 [Abstract] [Full Text] [Related]
19. [Effects of hyperbilirubinemia on distortion product otoacoustic emission, auditory brainstem response and mismatch negativity in guinea pigs]. Zhou X, Liang Y, Li Q, Ouyang TB, Tan ML. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr 01; 29(4):768-71. PubMed ID: 19403418 [Abstract] [Full Text] [Related]
20. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. Olgun Y, Kırkım G, Kolatan E, Kıray M, Bagrıyanık A, Olgun A, Kızmazoglu DC, Ellıdokuz H, Serbetcıoglu B, Altun Z, Aktas S, Yılmaz O, Günerı EA. Laryngoscope; 2014 Mar 01; 124(3):760-6. PubMed ID: 23900991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]